New Drug Approved for Soft-Tissue Cancer

FRIDAY, Oct. 23, 2015 — The chemotherapy drug Yondelis (trabectedin) has been approved by the U.S. Food and Drug Administration to treat certain soft-tissue sarcomas (STS) that have spread or can’t be treated by surgery.
STS can form anywhere, but…
Source: Topamax